Education
About Us
Working with TipRanks
Follow Us
Imunon (IMNN)
NASDAQ:IMNN
Earnings Data
Report Date
Mar 26, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.79Last Year’s EPS
-3.26Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call painted a positive picture with significant progress in clinical trials and strategic planning. Despite financial constraints, the company has managed to achieve regulatory endorsements and reduce operating costs significantly. The successful engagement with the scientific community and regulatory bodies adds to the optimistic outlook, although financial limitations remain a concern.Company Guidance
Progress in OVATION 3 Trial
OVATION 3 enrollment is surging ahead of plan, with nine patients randomized by the end of October, surpassing internal targets. The trial is evaluating IMNN-001 plus standard care for advanced ovarian cancer.
R&D Day Success
A successful R&D day was hosted in New York City, featuring renowned ovarian cancer opinion leaders, clinicians, and statistical experts, highlighting the transformative potential of IMNN-001.
Regulatory Milestones
The FDA has endorsed overall survival as a single study registration endpoint, meeting expectations for approval in Europe as well.
Financial Management and Cost Reductions
Operating expenses decreased by 31% year-over-year, with R&D expenses down 44% and CMC expenses down 52%.
Shareholder Equity and NASDAQ Compliance
NASDAQ compliance matter closed with shareholder equity at $4.1 million, well above the $2.5 million threshold.
IMNN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
IMNN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $3.95 | $4.16 | +5.32% |
Aug 05, 2025 | $8.00 | $7.62 | -4.75% |
May 12, 2025 | $10.43 | $10.64 | +2.01% |
Feb 27, 2025 | $10.49 | $10.56 | +0.67% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Imunon (IMNN) report earnings?
Imunon (IMNN) is schdueled to report earning on Mar 26, 2026, TBA (Confirmed).
What is Imunon (IMNN) earnings time?
Imunon (IMNN) earnings time is at Mar 26, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is IMNN EPS forecast?
IMNN EPS forecast for the fiscal quarter 2025 (Q4) is -0.79.